Cargando…
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
This study investigated whether rosiglitazone may affect breast cancer risk in female patients with type 2 diabetes mellitus in Taiwan. The reimbursement database of all female patients with type 2 diabetes mellitus under oral antidiabetic agents or insulin from 1996 to 2009 was retrieved from the N...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356862/ https://www.ncbi.nlm.nih.gov/pubmed/27936468 http://dx.doi.org/10.18632/oncotarget.13824 |